TYRA - Company ID 0001863127
The table below shows Tyra Biosciences, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $77.39M | $91.97M | $58.01M | $251.21M | $302.18M |
| Short-term investments | - | - | - | - | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $265.45M | $347.46M | $211.67M | $257.29M | $304.06M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $1.31M | $1.65M | $1.63M | $1.08M | $1.03M |
| Goodwill | - | - | - | - | - |
| Total assets | $282.61M | $363.56M | $225.86M | $266.18M | $306.70M |
| Accounts payable | $1.18M | $590.00K | $4.66M | $1.15M | $599.00K |
| Total current liabilities | $18.09M | $14.59M | $15.33M | $5.70M | $3.62M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $23.43M | $20.41M | $21.59M | $8.35M | $4.96M |
| Retained earnings | -$371.26M | -$251.31M | -$164.83M | -$95.70M | -$40.37M |
| Total equity | $259.18M | $343.15M | $204.26M | $257.83M | $301.74M |